Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02520726 · ClinicalTrials.gov registry record · Phase 4
PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims
A Phase 4 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT02520726: Clinical Trial Phase 4 study, sponsored by University of Utah.
NCT02520726 is a Phase 4 study that was terminated before completion, run by University of Utah. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02520726, a Phase 4 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled study to determine whether administration of sertraline to patients who exhibit acute stress disorder secondary to severe burns can contribute to the prevention of post-traumatic stress disorder (PTSD).
Interventions
- DRUG Placebo oral capsule
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-09 |
| Phase | Phase 4 |
Why NCT02520726 stopped before completion
NCT02520726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT02520726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02520726 about?
NCT02520726 is a clinical study titled "PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims". This is a randomized, double-blind, placebo-controlled study to determine whether administration of sertraline to patients who exhibit acute stress disorder secondary to severe burns can contribute to the prevention of post-traumatic stress disorder (PTSD).
What is the current status of trial NCT02520726?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2013-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02520726?
The interventions under investigation include: Placebo oral capsule (DRUG), Sertraline (DRUG).
Who is sponsoring clinical trial NCT02520726?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02520726's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia